$2,773.06 travel Payment -- Bristol-Myers Squibb to Dr. Donna Morgan
Bristol-Myers Squibb covers $2,773.06 in travel and lodging for Hepatology physician.
This page provides a detailed analysis of a $2,773.06 travel payment from Bristol-Myers Squibb to Dr. Donna Morgan. Data is from the CMS Open Payments (Sunshine Act) database.
Payment Details
| Field | Value |
|---|---|
| Amount | $2,773.06 |
| Payment Type | travel |
| Payment Nature | Travel and Lodging |
| Pharmaceutical Company | Bristol-Myers Squibb |
| Physician | Dr. Donna Morgan |
| NPI Number | 1912250736 |
| Physician Specialty | Hepatology |
| Location | Cambridge, MA |
| Date of Payment | 2025-12-05 |
| Conflict Assessment | Moderate -- Worth Noting |
AI-Powered Analysis of This Payment
The following analysis was generated by artificial intelligence to help patients understand the context, significance, and implications of this pharmaceutical payment. This analysis is not medical or legal advice.
Bristol-Myers Squibb made a $2.8K travel payment to Donna Morgan, a Hepatology specialist in Cambridge, MA. The payment of $2,773.06 to Dr. Donna Morgan in Hepatology from Bristol-Myers Squibb covers travel and lodging. This payment was made on December 5, 2025, and is associated with NPI 1912250736. The payment ID is OP-MNK3XXEC-AFH3IQ, and the location was Cambridge, MA.
Patient Guidance: What This Payment Means for You
If you are a patient, this payment relates to travel and lodging expenses covered by a pharmaceutical company for your physician, which may be related to educational events or professional development. Always discuss your treatment options with your healthcare provider and ask about alternatives.
Payment Context: Is This Amount Normal?
Payments for travel and lodging are common in the pharmaceutical industry, particularly for physicians attending conferences or educational programs, and this amount is moderate within that context.
Regulatory Context: Sunshine Act Requirements
This payment falls under the Sunshine Act's reporting requirements for payments made by manufacturers of drugs, devices, or medical supplies to physicians and teaching hospitals.
Related Topics
This payment is related to the following healthcare transparency topics:
- pharmaceutical-payments
- physician-compensation
- travel-expenses
- hepatology
- bristol-myers-squibb
- open-payments
Understanding travel Payments
Travel and lodging payments cover transportation and accommodation expenses for physicians attending conferences, advisory board meetings, or speaking engagements sponsored by pharmaceutical companies. These payments can be substantial, particularly for international travel or multi-day events.
Frequently Asked Questions About This Payment
What was this $2.8K payment for?
This was a travel payment of $2.8K from Bristol-Myers Squibb to Donna Morgan, categorized as "Travel and Lodging". The payment was reported under the Sunshine Act (CMS Open Payments).
Does Donna Morgan accept pharmaceutical money?
Yes, Donna Morgan received this $2.8K payment from Bristol-Myers Squibb. Under the Sunshine Act, pharmaceutical companies must report all payments to physicians exceeding $10. You can view Donna Morgan's full payment history on the CMS Open Payments database or on this site.
Is it legal for doctors to accept pharma payments?
Yes, it is legal for physicians to receive payments from pharmaceutical companies. The Physician Payments Sunshine Act (2010) requires transparency by mandating that companies report all payments exceeding $10 to CMS. These payments include consulting fees, meals, travel, speaking fees, and research grants. The law does not prohibit payments but ensures public disclosure.
Should I be concerned about this travel payment?
A travel payment of $2.8K should be evaluated in context. Payment does not imply wrongdoing, but patients have the right to ask their doctor about pharmaceutical relationships.
How do I talk to my doctor about pharma relationships?
You can ask your doctor directly: "Do you receive payments from pharmaceutical companies?" and "Does this affect which medications you prescribe?" Most doctors will answer honestly. You can also verify payment data yourself through CMS Open Payments (openpaymentsdata.cms.gov). Consider asking about generic alternatives and whether the prescribed medication is the best option regardless of manufacturer relationships.
What types of pharma payments are most concerning?
Ownership interests and large consulting/speaking fees are generally considered more significant than meals or small educational grants. Research payments typically fund clinical studies and are common in academic medicine. The total volume and concentration of payments from a single company may be more telling than any individual payment. Patterns matter more than individual transactions.
Does pharma money affect what my doctor prescribes?
Research shows that even small payments can influence prescribing behavior. Studies published in JAMA Internal Medicine found that physicians who received meals costing as little as $20 were more likely to prescribe the promoted brand-name drug. However, many physician-industry interactions are legitimate professional activities. The key is transparency and awareness.
How does this compare to other doctors in Hepatology?
To compare this payment against Hepatology averages, check the full specialty breakdown on CMS Open Payments. Payment amounts vary widely by specialty and type. Hepatology physicians may receive payments for consulting, speaking, or research that are standard for the field. Individual payments should be evaluated in the context of the doctor's full payment history.
What does this payment reveal about Donna Morgan's relationship with Bristol-Myers Squibb?
The payment specifically covers 'Travel and Lodging', indicating expenses related to professional activities. This $2.8K travel payment is part of the transparency data reported under the Sunshine Act.
Is this payment amount typical for Hepatology?
The amount is a single transaction, suggesting a specific event or series of related travel.
What should patients do after learning about this payment?
If you are a patient, this payment relates to travel and lodging expenses covered by a pharmaceutical company for your physician, which may be related to educational events or professional development.
What else should I know about this travel payment?
The payment date is in the future (December 5, 2025), which is unusual for reported data.
Related Reports
Data from CMS Open Payments. Payment does not imply wrongdoing. Consult your healthcare provider about any concerns.